Generex Announces Appointment of Executive Management Team
|
|
- Arnold Shaw
- 5 years ago
- Views:
Transcription
1 Generex Announces Appointment of Executive Management Team Company Integrates Latest Acquisition and Builds Corporate Foundation for Growth MIRAMAR, FL, November 15, Generex Biotechnology Corporation ( (OTCQB:GNBT) ( announced today that, following the successful completion of the recently announced acquisition of the operating assets of the Veneto Group and the establishment of a wholly-owned subsidiary, NuGenerex Distribution Solutions, the Company is now fully operational as a fullservice management services organization (MSO) in five states, with an aggressive growth strategy designed to expand the model to an additional 20+ states in the next several months. As part of the integration, several executives from the Veneto Group have joined the executive management team of Generex, providing both a foundation for growth of the MSO model as well as leadership to advance the corporate strategy for the parent company. This is a pivotal time in the evolution of Generex as we expand our business into management services operations and pharmacy distribution solutions. This expansion of our executive management team demonstrates our commitment to manage and grow the operations of Generex throughout the healthcare industry, said Joe Moscato, CEO of Generex. I would like to welcome our new 100+ employees to the family of Generex companies. These seasoned professionals bring a wealth of experience to complement our current leadership and will be an integral part of the team as we execute on our strategic plan to offer end-to-end, patient centric solutions for doctors, hospitals, and ancillary health service providers that optimize the doctor-patient relationship and improve health outcomes. Mr. Terry Thompson, COO of Generex and new President of NuGenerex Distribution Solutions added, We are extremely proud to announce the appointment of Steve Worster as Chief Compliance Officer, Brad Guy Chief Human Resources Officer, Roger Ivey as EVP & General Counsel, and Dick Seudkamp as EVP of Finance and Accounting. We are fortunate to have such an experienced and well-respected group join our executive team. Because of their expertise, professionalism, together and teamwork, we have been able to accomplish this integration in a very short period and we look forward to working together. Joe Moscato, Chief Executive Officer will lead the Generex management team, which includes: Terry Thompson, President, Chief Operating Officer, will continue to direct the Company s operations, acquisitions, assimilations and strategic growth initiatives. Page 1 of 5
2 Mark Fletcher, Esq., Executive Vice President, General Counsel & Secretary will continue leading the Company s corporate governance, SEC compliance, and M&A activities in addition to his corporate duties. Jason Terrell, MD, Chief Medical & Scientific Officer will continue to provide medical, clinical, and regulatory oversight of the Company s healthcare strategy and clinical development efforts for drugs, diagnostics, and medical devices. Additionally, he heads medical review for the company s M&A efforts. Anthony Crisci, Esq., CPA, GM & in-house Counsel, provides M&A support for all operating units including contracting, credentialing and legal coordination with both government and private contracting, banking solutions, and on-site problem resolution. Andrew Ro, Chief Investment Officer, will continue his role in leading the investment strategies for the Company and will spearhead plans to expand product reach in international markets, particularly in Asia. Richard Purcell, Executive Vice President, Research & Development, will continue in his role of guiding the clinical, regulatory, and commercial development of the Company s pipeline of new drug and medical devices. He will also be involved with strategic planning, business development and M&A evaluation. Mark Corrao, Chief Financial Officer will continue in his role overseeing corporate finance and SEC financial filings. The bios of the new leadership for NuGenerex Distribution Solutions acquired with the Veneto acquisition include: Dick Suedkamp will become Executive Vice President of Finance at NuGenerex Distribution Solutions, where he will manage finance and accounting. Prior to NuGenerex, Dick spent two years in finance and accounting leadership roles at Veneto Holdings and most recently served as Chief Financial Officer. During his tenure, Dick was instrumental in building out the finance and accounting business support capabilities and function at Veneto. Dick also spent almost 12 years in public accounting in the Big 4. He received his Bachelor of Business Administration and Master of Professional Accounting degrees from the University of Texas at Austin and is licensed as a CPA in the state of Texas. Roger Ivey will become General Counsel for NuGenerex Distribution Solutions, continuing a role he held at Veneto. Mr. Ivey brings deep and varied experience as in-house, healthcare and operations counsel. He also served as the Assistant General Counsel for StoneGate Senior Living, a large regional healthcare provider, was the Operations Counsel and sole in-house attorney for UDR, Inc. (a large publicly traded REIT) for five years and worked in private practice and as an Page 2 of 5
3 entrepreneur. Mr. Ivey began his career as a Judge Advocate General officer with the United States Army. He is an honor graduate of Pepperdine School of Law and an alumnus of the United States Military Academy at West Point. He is licensed to practice law in California and Texas. Steve Worster, Chief Compliance Officer for NuGenerex Distribution Solutions will be head of compliance and oversight for all compliance matters in the company. Mr. Worster has more than fifteen years of healthcare compliance experience including holding executive level positions with Cardinal Health and HMS. As part of his prior compliance rolls Mr. Worster has also been responsible for managing data security, physical security and business continuity programs. In addition to leading the compliance function, Mr. Worster will also act as the company s Chief Privacy Officer. Prior to working in compliance, Mr. Worster worked as a police officer for six years in suburban Columbus, Ohio and is a Veteran of the Air Force. He earned BA from The Ohio State University and his Juris Doctorate from Villanova University s Charles Widger School of Law. Brad Guy will become the company s head of human resources. Mr. Guy brings deep domain knowledge and experience in the areas of HR Strategy, Compensation and Benefits, Recruitment & Selection and Organization Design. He was previously the Vice President of Human Resources at Veneto Holdings. Mr. Guy brings a wealth of experience in healthcare, financial services, strategy consulting and consumer products having worked for publicly traded companies such as Alcon Laboratories, a subsidiary of Novartis Pharmaceuticals, Yum! Brands, Inc., CapitalOne as well as diversified money managers like Highland Capital Management, LLC and strategy consulting firms. Mr. Guy began his career in management consulting and executive search. He earned his MBA with distinction from the University of Dallas and his BBA from the University of North Texas. Moky Cheung, Chief Operating Officer, NuGenerex Distribution Solutions, will head operations and lead the growth strategy for the MSO business. Mr. Cheung brings over ten years of executive experience in healthcare and technology startups. Mr. Cheung was previously the Chief Operations Officer and Chief Information Officer at Veneto Holdings before joining NuGenerex Distribution Solutions. Mr. Cheung brings a wealth of knowledge in operational process efficiency, big data and business intelligence reporting and executive management. He has previously been part of two other start up exits and holds a Master of Science from Duke University and a Bachelor of Science from Johns Hopkins University. The depth and breadth of the team we have assembled allows us to operate with professional disciplines similar to large-scale companies. This will enable us to and quickly assimilate future acquisitions, Mr. Moscato concluded. Page 3 of 5
4 About Generex Biotechnology Corporation Generex is a strategic, diversified healthcare holdings company with offerings in a variety of services, diagnostics, medical devices, and pharmaceutical development. The Company s direct-to-patient services support its strategy of all-inclusive access to doctors, diagnostics, therapeutics, and additional health-related services to greatly improve the patient experience in receiving care. On the provider side, Generex s management services remove administrative burdens in multiple provider settings, including private practice and hospital, allowing doctors to devote more time to patient care. Revenue from the Company s subsidiaries will support clinical advancement of its wholly owned therapeutic products with a focus in immunotherapeutics based on stimulating critical members of the immune response, known as T helper cells, and its proprietary buccal administration of insulin. Cautionary Note Regarding Forward-Looking Statements This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forwardlooking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act. Page 4 of 5
5 Generex Contacts: Generex Biotechnology Corporation Joseph Moscato Todd Falls Extension 222 Russo Partners Investor / Media Contacts: Alex Fudukidis (646) alex.fudukidis@russopartnersllc.com Caroline Cunningham (212) Caroline.Cunningham@russopartnersllc.com Page 5 of 5
Generex Biotechnology Provides 2018 Year-End Summary & 2019 Plans
Generex Biotechnology Provides 2018 Year-End Summary & 2019 Plans - Acquisitions, Financing, Expansion Initiatives & Strategic Plans MIRAMAR, FL, January 22, 2019 - Generex Biotechnology Corporation (www.generex.com)
More informationCASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. Your Strategic Drug Development Partner in China NASDAQ: CASI WWW.CASIPHARMACEUTIALS.COM Forward Looking Statements This presentation contains forward-looking statements within
More informationManagement to Host Conference Call at 8:30 a.m. ET today
Aclaris Therapeutics Reports Second Quarter 2016 Financial Results August 11, 2016 7:01 AM ET Management to Host Conference Call at 8:30 a.m. ET today MALVERN, Pa., Aug. 11, 2016 (GLOBE NEWSWIRE) -- (NASDAQ:ACRS),
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K CURRENT REPORT
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationSeptember 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board
AGENDA SPECIAL CALLED TELEPHONE MEETING of THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS September 18, 2017 Austin, Texas Page CONVENE THE BOARD IN OPEN SESSION TO RECESS TO EXECUTIVE SESSION PURSUANT
More informationAcquisition of MST Medical Surgery Technologies Ltd:
Acquisition of MST Medical Surgery Technologies Ltd: Meaningfully Bolsters Senhance Platform Innovation to Further Advance Digital Laparoscopy September 24, 2018 2 FORWARD LOOKING STATEMENTS This presentation
More informationFinal Pitch Competition PROGRAM GUIDE. Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV
Final Pitch Competition PROGRAM GUIDE Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV #HITVenture #HIMSS16 1 Presented by: WEDNESDAY, MARCH
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 6-K. ALCON INC. (Registrant Name)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 April 2, 2019
More informationHFMA January CFO Forum
HFMA January CFO Forum January 26, 2018 St. Mark s Hospital Education Auditorium 1200 E. 3900 S. Salt Lake City, Utah 7.0 CPE hours 7:30 8:00 a.m. Continental Breakfast 8:00 8:15 a.m. Opening and Chapter
More informationGLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT
GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT CRITICAL THINKING AT THE CRITICAL TIME ABOUT US The Global Risk and Investigations Practice (GRIP) of FTI Consulting is the leading provider of
More informationCareer Education Corporation Bear Stearns 2007 SMid-Cap Investor Conference
Career Education Corporation Bear Stearns 2007 SMid-Cap Investor Conference November 13, 2007 Safe Harbor This presentation contains certain forward-looking statements, as defined in Section 21E of the
More informationCandidate Profile Form District Committee Election Joel Glasco
Candidate Profile Form District Committee Election Joel Glasco Candidate Name: Title: Managing Director - Market Manager Firm: Wells Fargo Adviso Candidate Biography and Personal Statement Candidate Biography
More informationKirkland Lake Gold Announces Management Appointments
NEWS RELEASE Kirkland Lake Gold Announces Management Appointments 1/3/2017 TORONTO, ONTARIO--(Marketwired - Jan. 3, 2017) - Kirkland Lake Gold Ltd. ("KL Gold" or the "Company") (TSX:KL), is pleased to
More informationBLUEKNIGHT ENERGY PARTNERS, L.P.
BLUEKNIGHT ENERGY PARTNERS, L.P. FORM 8-K (Current report filing) Filed 09/19/12 for the Period Ending 09/13/12 Address 201 NW 10TH, SUITE 200 OKLAHOMA CITY, OK, 73103 Telephone (405) 278-6400 CIK 0001392091
More informationGLP CHINA LEADERSHIP TRANSITION
For Immediate Release GLP CHINA LEADERSHIP TRANSITION Teresa Zhuge and Victor Mok promoted from within the China business to serve as Co-Presidents Dual leadership structure allows GLP to focus on strengthening
More informationALANCO TECHNOLOGIES INC
SECURITIES & EXCHANGE COMMISSION EDGAR FILING ALANCO TECHNOLOGIES INC Form: 8-K Date Filed: 2016-10-04 Corporate Issuer CIK: 98618 Copyright 2016, Issuer Direct Corporation. All Right Reserved. Distribution
More information2015 Real Estate Industry Update A landscape for change: Transforming for the future
2015 Real Estate Industry Update A landscape for change: Transforming for the future September 17, 2015 Welcome Welcome to Deloitte s 2015 real estate industry update The real estate industry has been
More informationPRINCIPAL FINANCIAL GROUP, INC. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationLAW ENFORCEMENT ASSOCIATES CORP
LAW ENFORCEMENT ASSOCIATES CORP FORM 8-K (Current report filing) Filed 08/31/09 for the Period Ending 08/27/09 Address 2609 DISCOVERY DRIVE SUITE 125 RALEIGH, NC, 27616 Telephone (919) 872-6210 CIK 0001165921
More informationINVESTOR PRESENTATION!
INVESTOR PRESENTATION ENHANCING HEALTH THROUGH CANNABIS SCIENCE WWW.EMERALDHEALTH.CA TSX.V:EMH TSX.V:EMH Disclaimer THE STATEMENTS MADE IN THIS PRESENTATION MAY INCLUDE FORWARD-LOOKING STATEMENTS REGARDING
More informationBRUKER CORP FORM 8-K. (Current report filing) Filed 06/07/12 for the Period Ending 06/04/12
BRUKER CORP FORM 8-K (Current report filing) Filed 06/07/12 for the Period Ending 06/04/12 Address 40 MANNING RD BILLERICA, MA, 01821 Telephone 978663-3660 CIK 0001109354 Symbol BRKR SIC Code 3826 - Laboratory
More informationThe Three Lines of Defense: Risk Management Supervision, Compliance and Internal Audit Monday, May 21 3:00 p.m. 4:00 p.m.
The Three Lines of Defense: Risk Management Supervision, Compliance and Internal Audit Monday, May 21 3:00 p.m. 4:00 p.m. Compliance and business supervision roles are becoming difficult to differentiate.
More informationFirst Southern Securities, LLC Credentials
First Southern Securities, LLC Credentials Table of Contents SECTION A SECTION B SECTION C SECTION D Overview of First Southern Securities, LLC......3 Services Offered...6 Trading Volume by Credit 1. Municipal...11
More information2,500,000 Shares. Common Stock
Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-201841 Prospectus Supplement No. 15 to Prospectus dated February 26, 2015 2,500,000 Shares Common Stock This Prospectus Supplement No. 15
More informationLISA TILTON-McCARTHY
LISA TILTON-McCARTHY Lisa Tilton-McCarthy received a B.A. in English from Texas A&M University in College Station and graduated summa cum laude from South Texas College of Law in Houston. She was Editor-in-Chief
More informationOUR BELIEFS W H E R E W E A R E F O C U S E D
ABOUT US Formed in 1987, the Gideon Group, Inc. has helped entrepreneurs, project developers and commercial real estate developers raise over $1 billion in startup and expansion capital. We bring a unique
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K. Conformis, Inc. (Exact Name of Company as Specified in Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More information1000 Urlin Avenue #A18 Columbus, Ohio Bill Diffenderffer. September 2013 to Present. Lecturer on Entrepreneurship : MBA and Undergraduate
1000 Urlin Avenue #A18 Columbus, Ohio 43212 Mobile: 214-616-8711 E-mail: bdiffenderffer@msn.com Bill Diffenderffer Business History September 2013 to Present The Ohio State University Lecturer on Entrepreneurship
More informationWASHINGTON,D.C FORM8-K. CURRENTREPORT PursuanttoSection13or15(d)ofthe. Date of Report (Date of the earliest event reported): October29,2018
UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION WASHINGTON,D.C.20549 FORM8-K CURRENTREPORT PursuanttoSection13or15(d)ofthe SecuritiesExchangeActof1934 Date of Report (Date of the earliest event reported):
More informationAtento S.A. (Translation of Registrant s name into English)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month
More informationFSIC FRANCHISE. Frequently asked questions
Frequently asked questions FSIC FRANCHISE 1. What are the details of the announced transaction? FS Investments ( FS ) and KKR Credit ( KKR ) announced an agreement to form a partnership to provide investment
More informationMAXWELL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationPACIFIC DRILLING S.A.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Date of Report:
More informationJOHN JACK R. TUPMAN, JR CURRICULUM VITAE
JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant
More informationTRACY SEWARD CPA DECEMBER 2015 PAGE 1
TRACY SEWARD CPA Tracy Seward has over 20 years of financial accounting experience obtained through a diverse range of industry and senior management experience. He is a team leader devoted to creating
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationUnited States SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K
United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 19, 2016 Date of report (date
More informationPRESENTERS >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
PRESENTERS >>>>>>>>>> Paula Rosput Reynolds President and Chief Executive Officer Mike Hughes Executive Vice President Insurance Operations Paula Rosput Reynolds is president and chief executive officer
More informationMOODY S CORPORATION (Exact Name of Registrant as Specified in Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event
More informationConference Speakers. Bo Armstrong, DataPath, Director of Marketing
Conference Speakers Bo Armstrong, DataPath, Director of Marketing Bo Armstrong leads all marketing initiatives for DataPath and its subsidiaries. He joined DataPath in 2015 and has over 15 years of marketing
More informationAcquisition of GEODynamics. December 13, 2017
Acquisition of GEODynamics December 13, 2017 Forward-looking Statements We include the following cautionary statement to take advantage of the "safe harbor" provisions of the Private Securities Litigation
More informationKELSO TECHNOLOGIES INC.
CC BY-SA KELSO TECHNOLOGIES INC. CORPORATE PRESENTATION DISCLAIMER Legal Notice Regarding Forward Looking Statements This presentation contains forward-looking statements within the meaning of applicable
More informationUS FOODS HOLDING CORP. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 12, 2017 (January 11, 2017)
More informationCBBS CENTRAL OFFICE STAFF
Professional Association Management Government Relations Business Consulting CBBS CENTRAL OFFICE STAFF www.advocal.com 1000 Q Street, Suite 200 Sacramento, California 95811-6518 The CBBS Executive Team
More informationFor personal use only
2011 Annual General Meeting December 1, 2011 NASDAQ (UNIS) and ASX (UNS) Cautionary Note Regarding Forward-Looking Statements This presentation contains forward looking statements under the safe harbor
More informationAsk the Regulator and Industry Experts Thursday, September 14 3:30 p.m. 4:30 p.m.
Ask the Regulator and Industry Experts Thursday, September 14 3:30 p.m. 4:30 p.m. During this session, panelists answer your questions related to the fixed income regulatory landscape. Panelists also address
More informationHOTELS, TOURISM & LEISURE. Hotels, Tourism & Leisure
HOTELS, TOURISM & LEISURE nem is one of Australasia s largest boutique business consultancy firms, which is able to draw on the significant skills and experience of over 50 partners across Australia and
More informationMark-Up Disclosure Requirements Thursday, September 14 2:15 p.m. 3:15 p.m.
Mark-Up Disclosure Requirements Thursday, September 14 2:15 p.m. 3:15 p.m. This session focuses on FINRA and MSRB mark-up disclosure requirements. Panelists discuss securities covered by the new rule,
More informationTeresa V. Pahl Partner
Teresa represents clients in all phases and aspects of their businesses. Teresa s expertise includes matters involving general corporate law, securities law and real property law. Teresa works with early-stage
More information$3.5 Billion Acquisition of Nation s No. 2 Company in Growing Moist Snuff Category. Deal at a Glance
Reynolds American Enters Smokeless Tobacco Category Via Acquisition of Conwood $3.5 Billion Acquisition of Nation s No. 2 Company in Growing Moist Snuff Category Deal at a Glance 2005 Financial Summary
More information2015 Real Estate Industry Update A landscape for change: Transforming for the future
2015 Real Estate Industry Update A landscape for change: Transforming for the future December 11, 2015 Welcome Welcome to Deloitte s 2015 real estate industry update The real estate industry has been on
More informationWILSON SONSINI GOODRICH & ROSATI
WILSON SONSINI GOODRICH & ROSATI IS PLEASED TO ANNOUNCE THAT THE FOLLOWING ATTORNEYS HAVE BECOME PARTNERS AT THE FIRM. Troy Foster Corporate & Securities, Palo Alto Jessica L. Margolis Litigation, New
More informationVantiv, now Worldpay Investor Relations
Vantiv, now Worldpay Investor Relations Connecting to financial markets Conversing with investors and shareholders Executive Officers Charles Drucker Executive Chairman and Co-Chief Executive Officer Charles
More informationCavco Industries Annouces Executive Leadership Changes
Cavco Industries Annouces Executive Leadership Changes (Note: typo in the headline above part of the original press release via Globenewswire) November 08, 2018 17:11 ET Source: Cavco Industries, Inc.
More informationASHFORD HOSPITALITY TRUST PREFERENCE IN SECOND QUARTILE OF NYSE SCORECARD
Published by News Bites on June 6, 2016. Available on Lexis Advance. ASHFORD HOSPITALITY TRUST PREFERENCE IN SECOND QUARTILE OF NYSE SCORECARD News Bites - People in Business June 6, 2016 Monday Ashford
More informationCourse Name: Financial Executives Roundtable
Course Name: Financial Executives Roundtable Speakers: Beth Bull, Communities Foundation of Texas David Chavenson, Alon USA Energy Company Loren Greaves, The Rosewood Corporation Paul Willey (Moderator),
More informationQI Comes of Age: Health Reform Accelerates
12 th Annual ATP Alumni Conference QI Comes of Age: Health Reform Accelerates February 15-17, 2017 At Newpark Resort in Park City, Utah 2009 ATP Alumni Conference. February 10-12, 2010, Newpark Resort,
More informationRonald Blue & Co., Thrivent Trust Co. join and expand as nationwide trust company
FOR IMMEDIATE RELEASE FOR MORE INFORMATION CONTACT: August 2, 2017 Ty Mays @ (770) 256-8710 tmays@paragoncommunications.net Ronald Blue & Co., Thrivent Trust Co. join and expand as nationwide trust company
More informationThe Fortress Group at Morgan Stanley
The Fortress Group at Morgan Stanley 1 PENN PLAZA, 43RD FL NEW YORK, NY 10119 212-643-5781 / MAIN 800-223-4565 / TOLL-FREE 212-714-2546 / FAX http://www.morganstanleyfa.com/thefortressgroup lane.h.katz@ms.com
More informationThelander 2016 PRIVATE COMPANY YEAR END MERIT INCREASE PITCHBOOK REPORT. J. Thelander Consulting
Thelander 2016 PRIVATE COMPANY YEAR END MERIT INCREASE PITCHBOOK REPORT J. Thelander Consulting 165 Marlin Mill Valley, CA 94941 jt@jthelander.com jthelander.com +1 415.383.7006 Legal Notice: The Thelander
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationThe MoneyTree Report. Overview of Venture Capital Investments Third Quarter 2009
The MoneyTree Report Overview of Venture Capital Investments Third Quarter 2009 PricewaterhouseCoopers/National Venture Capital Association MoneyTree Report based on data from Thomson Reuters 1 Host of
More informationViking Advisory Group. Company Presentation September 2011
Viking Advisory Group Company Presentation September 2011 Viking Advisory Group Mission To offer value added, high quality services within the disciplines of financial management, accounting, legal, insurance,
More informationSecond Wednesday s. June 9, Planning for Future County Facility Needs
Second Wednesday s June 9, 2010 Planning for Future County Facility Needs PROGRAM DESCRIPTION In a time of declining resources and increased public demand for services, county building improvements must
More informationDean A. Connor. President & Chief Executive Officer, Sun Life Financial
Dean A. Connor President & Chief Executive Officer, Sun Life Financial Dean A. Connor was appointed President & Chief Executive Officer, Sun Life Financial on December 1, 2011, and is a member of the company
More informationCATALENT PHARMA SOLUTIONS, INC.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event
More informationLISA ROTH MONAHAN & ROTH, LLC 630 FIRST AVENUE SAN DIEGO, CA 92101
LISA ROTH MONAHAN & ROTH, LLC 630 FIRST AVENUE SAN DIEGO, CA 92101 BACKGROUND Lisa Roth is the of Monahan & Roth, LLC, a regulatory compliance company providing services including professional consultations,
More informationGardner Denver Holdings, Inc. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date Earliest Event
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event
More informationMarlene A. Casini is a Chartered Advisor in Philanthropy (CAP). She joined the Foundation in 2005 from Cleveland where she served as an executive for
Marlene A. Casini is a Chartered Advisor in Philanthropy (CAP). She joined the Foundation in 2005 from Cleveland where she served as an executive for the Cleveland Clinic Foundation, as Vice President
More informationRobert A. Greising Partner
Robert A. Greising Partner P: (317) 238-6215 F: (317) 636-1507 E: rgreising@kdlegal.com Indianapolis Office One Indiana Square Suite 2800 Indianapolis, IN 46204-2079 Robert Greising is a Partner in the
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationBeleave Signs Agreement to Acquire 250,000 Square Feet of Greenhouse Space and 85 Acres of Land to Expand its Production Capabilities
Beleave Signs Agreement to Acquire 250,000 Square Feet of Greenhouse Space and 85 Acres of Land to Expand its Production Capabilities Toronto, ON September 6, 2018 Beleave Inc. (CSE: BE) (OTCQX: BLEVF)
More informationHERSHORIN & HENRY, LLP. Thomas S. Van Contract Partner
HERSHORIN & HENRY, LLP ATTORNEYS AT LAW IS PLEASED TO ANNOUNCE THAT Thomas S. Van Contract Partner HAS JOINED OUR FIRM Mr. Van has over 14 years of experience in successfully handling Business Litigation,
More informationHealth Care Expert Panel Bios
Health Care Expert Panel Bios Norman C. Mosrie (Chair) Norman is a partner with DHG Healthcare in the Charleston, WV office. His over 30 years of experience includes providing a wide variety of audit and
More informationHFMA January CFO Forum
HFMA January CFO Forum January 26, 2018 St. Mark s Hospital Education Auditorium 1200 E. 3900 S. Salt Lake City, Utah 7.0 CPE hours 7:30 8:00 a.m. Continental Breakfast 8:00 8:15 a.m. Opening and Chapter
More informationCLIFFS NATURAL RESOURCES INC.
CLIFFS NATURAL RESOURCES INC. FORM 8-K (Current report filing) Filed 10/17/07 for the Period Ending 10/15/07 Address 200 PUBLIC SQUARE STE. 3300 CLEVELAND, OH 44114-2315 Telephone 216-694-5700 CIK 0000764065
More informationJD Hickey, M.D. President and Chief Executive Officer
COMPANY LEADERSHIP BlueCross BlueShield of Tennessee, Inc., an Independent Licensee of the Blue Cross and Blue Shield Association The BlueCross and BlueShield Associationis an association of independent
More informationManagement Bios. Michael P. Norcio, Chairman and CEO
Michael P. Norcio, Chairman and CEO Michael P. Norcio is the Chairman and Chief Executive Officer of MAR, Incorporated (MAR), headquartered in Rockville, Maryland. MAR, Incorporated is a professional services
More informationOverview of Venture Equity
Overview of Venture Equity SVB Analytics Report 2017 Written by SVB Analytics: Steve Liu Managing Director sliu@svb.com Sean Lawson Senior Manager slawson2@svb.com Steven Pipp Senior Associate spipp@svb.com
More informationAccenture plc (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationthe practice of law the way it should be
at a glance A 200 attorney Firm with 50 partners in a single office where collaboration and collegiality are valued the practice of law the way it should be 100% attorney pro bono participation for over
More informationAssurant, Inc. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationCandidate Profile Form District Committee Election Kelly Anderson
Kelly Anderson Compliance Director RBC Capital Marke Kelly Anderson is Compliance Director at RBC Wealth Management, a division of RBC Capital Markets, LLC. Since 2004 she has been responsible for the
More informationWHO WE SERVE. Regulators Business and Law Schools. Executives and Staff Job Seekers & Students
RCA MISSION Protect investors and financial markets as the exclusive authority for compliance education, training, accreditation, certification, skills assessment, and employee development. 1 WHO WE SERVE
More informationIDEXX LABORATORIES, INC.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event
More informationLynn E. Turner Managing Director
Lynn E. Turner Managing Director 725 South Figueroa Street, Suite 2950 Los Angeles, CA 90017 main: 213.222.0870 fax : 888.222.6001 lturner@litinomics.com Lynn E. Turner is a Managing Director within the
More informationNasdaq: RNVA. Diagnostics and supportive software solutions to healthcare providers.
Nasdaq: RNVA Diagnostics and supportive software solutions to healthcare providers. Forward looking Statements and Non-GAAP Information This presentation includes forward-looking statements about Rennova
More informationThe Wood Group at Morgan Stanley. Understanding Your Vision, Earning Your Trust
The Wood Group at Morgan Stanley Understanding Your Vision, Earning Your Trust WHY THE WOOD GROUP The Culture of Family is in Our DNA Our Team was formed to provide our Clients and their Families with
More informationDaseke Adds Three Companies; Annual Revenue Run Rate Grows to $1.2 Billion
NEWS RELEASE Daseke Adds Three Companies; Annual Revenue Run Rate Grows to $1.2 Billion 12/4/2017 Growing from $30 million in nine years ADDISON, Texas--(BUSINESS WIRE)-- Daseke,Inc. (NASDAQ: DSKE) (NASDAQ:
More informationWRITTEN SUBMISSION OF GE CAPITAL TO THE FINANCIAL CRISIS INQUIRY COMMISSION
WRITTEN SUBMISSION OF GE CAPITAL TO THE FINANCIAL CRISIS INQUIRY COMMISSION MICHAEL A. NEAL CHAIRMAN AND CEO OF GE CAPITAL AND VICE CHAIRMAN OF GE May 6, 2010 Chairman Angelides, Vice-Chairman Thomas,
More informationInvestor Presentation. August 2017 OTCQB: ZYXI
Investor Presentation August 2017 Forward Looking Statements Statements made in this presentation include financial estimates and forwardlooking statements that are not historical facts. Each of these
More informationInvestor Presentation. June 2006
Investor Presentation June 2006 Forward-Looking Statements This presentation contains forward-looking statements that are subject to risks and uncertainties including, but not limited to, the impact of
More informationJ.Crew Group, Inc. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationRick Legleiter Appointed Chief Executive Officer, Chairman Succession and Board Renewal Process
Universal Biosensors, Inc. ARBN 121 559 993 1 Corporate Avenue Rowville Victoria 3178 Australia Telephone +61 3 9213 9000 Facsimile +61 3 9213 9099 Email info@universalbiosensors.com www.universalbiosensors.com
More informationBios. James R. Kruse. Richard Best
Bios James R. Kruse Since 1970, Jim has concentrated his practice on securities and corporate law, emphasizing new equity financings and corporate acquisitions and reorganizations involving publicly traded
More informationianthus Closes Acquisition of Citiva Medical and Citiva USA, Gaining Access to New York's Population of Approximately 20 Million People
February 1, 2018 ianthus Closes Acquisition of Citiva Medical and Citiva USA, Gaining Access to New York's Population of Approximately 20 Million People Company to Host a Conference Call at 9:00am ET on
More informationCautionary Statement Regarding Forward-Looking Statements
May 19, 2014 Cautionary Statement Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995,
More informationMara H. Rogers, Partner Norton Rose Fulbright
Mara H. Rogers Partner Norton Rose Fulbright US LLP New York T:+1 212 318 3206 F:+1 212 318 3400 mara.rogers@nortonrosefulbright.com vcard (+Outlook) Related services Corporate, M&A and securities Mergers
More informationEXECUTIVE COMMITTEE. David Wan. Maureen Betses. President & Chief Executive Officer. Executive Vice President, Higher Education
David Wan President & Chief Executive Officer David Wan is chief executive officer of Harvard Business Publishing. He joined the company in July 2002. Wan is a distinguished operating executive with 30
More information